Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping Using Optical Coherence Tomography

NCT03420846 is registered in ClinicalTrials.gov with Michelson Diagnostics Ltd. as lead sponsor.

NCT NCT03420846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03420846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping Using Optical Coherence Tomography
Lead sponsor
Michelson Diagnostics Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
July 1, 2018
Completion date
September 1, 2019
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, basal cell